Harbin Pharmaceutical Group Co., Ltd.

SHSE:600664 Stock Report

Market Cap: CN¥9.9b

Harbin Pharmaceutical Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure2.2yrs
Board average tenure2.5yrs

Recent management updates

Recent updates

Harbin Pharmaceutical Group Co., Ltd. (SHSE:600664) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 25
Harbin Pharmaceutical Group Co., Ltd. (SHSE:600664) Looks Inexpensive But Perhaps Not Attractive Enough

Investors Aren't Buying Harbin Pharmaceutical Group Co., Ltd.'s (SHSE:600664) Earnings

Jun 25
Investors Aren't Buying Harbin Pharmaceutical Group Co., Ltd.'s (SHSE:600664) Earnings

We Think Harbin Pharmaceutical Group (SHSE:600664) Can Manage Its Debt With Ease

May 25
We Think Harbin Pharmaceutical Group (SHSE:600664) Can Manage Its Debt With Ease

Harbin Pharmaceutical Group's (SHSE:600664) Anemic Earnings Might Be Worse Than You Think

Apr 17
Harbin Pharmaceutical Group's (SHSE:600664) Anemic Earnings Might Be Worse Than You Think

CEO

Harbin Pharmaceutical Group has no CEO, or we have no data on them.

Leadership Team

NamePositionTenureCompensationOwnership
Bo Jiang
CFO & VP3.9yrsCN¥1.31mno data
Xiaodong Meng
VP & Secretaryless than a yearCN¥1.31m0.013%
CN¥ 1.3m
Haitao Jiang
Vice President2.7yrsCN¥691.90k0.0019%
CN¥ 189.5k
Jicheng Xia
Vice President2.2yrsCN¥467.60k0.0032%
CN¥ 315.5k
Bangdong Li
Vice President2.2yrsCN¥578.60k0.0016%
CN¥ 157.8k

2.2yrs

Average Tenure

51yo

Average Age

Experienced Management: 600664's management team is considered experienced (2.2 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Aidong Lou
Independent Director3.9yrsCN¥150.00kno data
Weihong Lu
Independent Director3.9yrsCN¥150.00kno data
Zhaohua Li
Independent Director3.9yrsCN¥150.00kno data
Ying Lei
Independent Directorless than a yearno datano data
Xiaoping Hu
Chairman3.9yrsno datano data
Shiwei Yin
Director2.8yrsno datano data
Zhifeng Sun
Director2.5yrsno datano data
Fangju Qiu
Employee Supervisorless than a yearno data0.000080%
CN¥ 7.9k
Liu Mo
Directorless than a yearno datano data
Cheng Peng
Supervisorless than a yearno datano data
Wenguang Peng
Chairman of the Supervisory Boardless than a yearno datano data

2.5yrs

Average Tenure

49yo

Average Age

Experienced Board: 600664's board of directors are not considered experienced ( 2.5 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/20 18:13
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Harbin Pharmaceutical Group Co., Ltd. is covered by 8 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Xing Qiu LinAJ Securities Co., Ltd
Ling Bo TuChina Minzu Securities
Wayne HeChina Stock Investment Research Co. Ltd. (GZ500..com)